Assessment of chemokine serum levels in epithelial ovarian cancer patients

Tumori

Volumn 99, Issue 4, 2013, Pages 540-544

  Falcão Júnior, João Oscar Almeida ^a   Teixeira Carvalho, Andréa ^b   Can̂dido, Eduardo Batista ^c   Lages, Elisa Lopes ^a   Freitas G, Gustavo Ferreira ^a   Lamaita, Rívia Mara ^d   Bonfim, Lívia Paula Freire ^a   Salera, Rafael Borges ^a   Traiman P, Paulo ^a   Da Silva Filho, Agnaldo Lopes ^a,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Hospital Mater Dei   (Brazil)

Author keywords

CA 125; Chemokines; Cytometric bead array; Immune system; Ovarian cancer

Indexed keywords

INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOKINESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; LAPAROTOMY; MIDDLE AGED; OVARY CARCINOMA; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; CHEMOKINES; FEMALE; HUMANS; INTERLEUKIN-8; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890891466     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1361.15108     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin, 60: 277-300, 2010.
2. Brewer MA, Johnson K, Follen M, Gershenson D, Bast R Jr: Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res, 9: 20-30, 2003.
3. Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 7: 211-217, 2005.
4. Wong MM, Fish EN: Chemokines: attractive mediators of the immune response. Semin Immunol, 15: 5-14, 2003.
5. Wang JM, Deng X, Gong W, Su S: Chemokines and their role in tumor growth and metastasis. J Immunol Methods, 220: 1-17, 1998.
6. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer, 4: 540-550, 2004.
7. Luster AD: The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol, 14: 129-135, 2002.
8. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M: Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol, 111: 1185-1199, 2003.
9. Yoshie O: Role of chemokines in trafficking of lymphocytes and dendritic cells. Int J Hematol, 72: 399-407, 2000.
10. DiSaia PJ, Bloss JD: Treatment of ovarian cancer: new strategies. Gynecol Oncol, 90: S24-32, 2003.
11. Schottenfeld D, Beebe-Dimmer J: Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, 56: 69-83, 2006.
12. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res, 61: 4961-4965, 2001.
13. Moser M, Murphy KM: Dendritic cell regulation of TH1-TH2 development. Nat Immunol, 1(3):199-205, 2000.
14. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J: Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol, 110: 252-266, 2004.
15. Pierangeli SS, Silva LK, Harris EN: A flow cytometric assay for the detection of antiphospholipid antibodies. Am Clin Lab, 18: 18-19, 1999.
16. Lund-Johansen F, Davis K, Bishop J, de Waal Malefyt R: Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions. Cytometry, 39: 250-259, 2000.
17. Freedman RS, Ma Q, Wang E, Gallardo ST, Gordon IO, Shin JW: Migration deficit in monocyte-macrophages in human ovarian cancer. Cancer Immunol Immunother, 57: 635-645, 2008.
18. Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT: Multiplexed immunobeadbased cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 14: 981-987, 2005.
19. Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE: Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer, 10: 33-41, 2000.
20. Fader AN, Rasool N, Vaziri SA, Kozuki T, Faber PW, Elson P: CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes. Anticancer Res, 30: 4791-4798, 2010.
21. Jiang YP, Wu XH, Xing HY, Du XY: Role of CXCL12 in metastasis of human ovarian cancer. Chin Med J (Engl), 120: 1251-1255, 2007.